Enzo Biochem (ENZ) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of product revenues: 3.31M
Today's EPS Names:
LVWD, FWDI, GO, More
Financial Fact:
Cost of product revenues: 3.31M
Today's EPS Names:
LVWD, FWDI, GO, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.16 million versus the consensus estimate of $24.5 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
